Abstract
Plants of the genus Terminalia are amongst the most widely used plants for traditional medicinal purposes worldwide. Many species are used for their antibacterial, antifungal, antiprotozoal, antiviral, antidiarrhoeal, analgesic, antimalarial, antioxidant, antiinflammatory and anticancer activities. Wound healing and cardiovascular effects have also been credited to some species. Many Terminalia species have multiple beneficial effects for multiple diseases and ailments. Indeed, the Indian species Terminalia chebula is known as the king of plants in Ayurveda due to its broad range of medicinal uses. However, apart from the reported ethnopharmacological uses of many Terminalia species, surprisingly few studies have rigorously examined this important genus for their medical properties/mechanisms and phytochemistry. This is likely due to the high tannin content common to many Terminalia species and the perception that these tannins may be responsible for much of their beneficial properties. As the complexities of tannins make them poor candidates for drug design, most interest in Terminalia species has been for their pharmacognostic and nutraceutical value and they have often been overlooked as potentials for drug discovery. However, recent reports have identified many other interesting phytochemicals and demonstrated that these may be responsible for several of the reported bioactivities of the Terminalia species used in traditional medicinal systems. The last decade has seen a large increase in the number of studies into the use of Terminalia species as therapeutic agents. Several species used in Ayurvedic medicine (Terminalia arjuna, Terminalia bellerica, Terminalia catappa, T. chebula) in particular have received much recent attention. Similarly, recent reports have also highlighted the medicinal potential of species from Africa, Australia and the Americas. The aim of this report is to summarise the recent research into the medicinal properties, phytochemistry and therapeutic mechanisms of Terminalia species and thus to highlight and direct future areas of research into the medicinal activities of this important genus.
Similar content being viewed by others
References
Adentunji VO, Salawu OT (2010) Efficacy of ethanolic leaf extracts of Carica papaya and Terminalia catappa as molluscicides against the snail intermediate hosts of schistosomiasis. J Med Plants Res 4(22):2348–2352
Agarwal S, Kulkarni GT, Sharma VN (2011) A comparative study on the antioxidant activity of methanolic extracts of Terminalia paniculata and Madhuca longifolia. Free Radic Antioxid 1(4):62–68
Agbedahunsi JM, Anao I, Adewunmi CO, Croft SL (2006) Trypanocidal properties of Terminalia ivorensis A. Chev (Combretaceae). Afr J Complement Altern Med 3(2):51–56
Ahmed SM, Swamy BM, Gopkumar V, Dhanapal R, Chandrashekara VM (2005) Anti-diabetic activity of Terminalia catappa Linn. Leaf extracts in Alloxan-induced diabetic rats. Iran J Pharmacol Therapeutics 4(1):36–39
Ahsan H, Hadi SM (1998) Strand scission in DNA induced by curcumin in the presence of Cu(II). Cancer Lett 124:23–30
Aimola A, Inuwa HM, Mamman AI, Habila N, Agbaji AS, Omoniwa D (2011) Terminalia catappa extract enhances erythropoiesis in adult Balb C mice. J Mol Biol Res 1(1):40–46
Akinyemi KO, Oladapo O, Okwara CE, Ibe CC, Fasure KA (2005) Screening of crude extracts of six medicinal plants used in South-West Nigerian unorthodox medicine for anti-methicillin resistant Staphylococcus aureus activity. BMC Complement Altern Med 5:6
Alayande LB, Alayande MO, Mohammed AA, Adamu T, Abubakar U, Daneji A, Ajagbonna OP (2011) Efficacy of Terminalia avicennoides and its combination with diminazene aceturate (Berenil®) in rats experimentally infected with Trypanosoma brucei brucei. Sokoto J Vet Sci 9(2):11–15
Ali A, Kaur G, Hayat K, Ali M, Ather M (2003a) A novel naphthanolglycoside from Terminalia arjuna with antioxidant and nitric oxide inhibitory activities. Pharmazie 58:932–934
Ali A, Kaur G, Hamid H, Abdulla T, Ali M, Niwa M, Alam MS (2003b) Terminoside A, a newtriterpine glycoside from the bark of Terminalia arjuna inhibits nitric oxide production in murine macrophages. J Asian Nat Prod Res 5:137–142
Aliyu ZY, Gordeuk V, Sachdev V, Babadoko A, Mamman AI, Akpanpe P, Attah E, Suleiman Y, Aliyu N, Yusuf J et al (2008) Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria. Am J Hematol 83:485–490
Anam K, Suganda AG, Sukandar EY, Broto L, Kardono S (2010) Antibacterial effect of component of Terminalia muelleri Benth against Staphylococcus aureus. Int J Pharmacol 6(4):369–374
Aneja KR, Joshi R (2009) Evaluation of antimicrobial properties of fruit extracts of Terminalia chebula against dental caries pathogens. Jundishapur J Microbiol 2(3):105–111
Aneja KR, Sharma C, Joshi R (2012) Antimicrobial activity of Terminalia arjuna Wight & Arn: an ethnomedicinal plant against pathogens causing ear infection. Braz J Otorhinolaryngol 78(1):68–74
Anjaneyulu ASR, Prasad AVR (1982a) Chemical examination of roots of Terminalia arjuna (Roxb.) Wight & Arnot. Part I. Characterisation of two new triterpenoid glycosides. Indian J Chem 21B:530–533
Anjaneyulu ASR, Prasad AVR (1982b) Chemical examination of roots of Terminalia arjuna—the structure of arjunoside III and arjunoside IV, two new triterpenoid glycosides. Phytochemistry 21:2057–2060
Anjaneyulu ASR, Prasad AVR (1983) Structure of terminic acid, a dihydroxy triterpene carboxylic acid from Terminalia arjuna. Phytochemistry 22:993–998
Araya-Maturana R, Heredia-Moya J, Donoso-Tauda O, Vera M, Toledo Hernández J, Pavani M, Pessoa-Mahana H, Weiss-López B, Ferreira J (2008) Effects of simple and angular chromones on tumor cell respiration. Nat Prod Commun 3(4):519–525
Astaneie F, Afshari M, Mojtahedi A, Mostafalou S, Zamani MJ, Larijani B, Abdollah M (2005) Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients. Arch Med Res 36(4):376–381
Awad AB, Toczek J, Carol CS, Fink S (2004) Phytosterols decrease prostaglandin release in cultured P388D1/MAB macrophages. Prostaglandins Leukot Essent Fatty Acids 70(6):511–520
Baker A, Payne CM, Briehl MM, Powis G (1997) Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo. Cancer Res 57:5162–5167
Baliga MS (2010) Triphala, Ayurvedic formulation for treating and preventing cancer: a review. J Altern Complement Med 16(12):1301–1308
Balleisen L, Gay S, Marx R, Kuhn K (1975) Comparative investigation of the influence of human and bovine collagen types I, II and III on the aggregation of human platelets. Wein Klin Wechenschr 53:903–905
Betterle C, Zanette F, Pedini B, Presotto F, Rapp LB, Monciotti CM, Rigon F (1984) Clinical and subclinical organ-specific autoimmune manifestations in type I (insulin-dependent) diabetic patients and their first-degree relatives. Diabetologia 26:431–436
Bhatia J, Bhattacharya SK, Mahajan P, Dwivedi S (1998) Effect of Terminalia arjuna on coronary flow—an experimental study (Abstract). Indian J Pharmacol 30:118
Biswas M, Biswas K, Karan TK, Bhattacharya S, Ghosh AK, Haldar PK (2011) Evaluation of analgesic and anti-inflammatory activities of Terminalia arjuna leaf. J Phytol 3(1):33–38
Brown NS, Bicknell R (2001) Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potentialand response to therapy of breast cancer. Breast Cancer Res 3:323–327
Carluccio MA, Sicuella L, Ancora MA, Massaro M, Scoditti E, Storelli C, Visioli F, De Caterina DAR (2003) Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thrombos Vasc Biol 23:622–629
Chang CL, Lin CS (2012) Phytochemical composition, antioxidant activity, and neuroprotective effect of Terminalia chebula Retzius extracts. Evid Based Complement Altern Med article ID 125247
Chattopadhyay RR, Battacharyya SK (2007) Plant review: terminalia chebula: an update. Pharmacogn Rev 1(1):151–156
Chaudhari M, Mengi S (2006) Evaluation of phytoconstituents of Terminalia arjuna for wound healing activity in rats. Phytother Res 20:799–805
Cheng HY, Lin CC, Lin TC (2002) Antiherpes simplex virus type 2 activity of casuarinin from the bark of Terminalia arjuna Linn. Antivir Res 55:447–455
Cherikoff V, Kowalski G (2008) Superfoods for Superhealth. Discover the Wonders of Australian Native Fruits. [Last cited on 2010 Oct 07]. Available from: http://www.kakadujuice.com/clientinc/upload/Promotional.Tools/SuperFoods%20Excerpt.pdf
Chitsulo L, Engels D, Montresor A, Savioli L (2000) The global status of schistosomiasis and its control. Acta Trop 77:41–51
Choi S, Chung MH (2003) A review on the relationship between Aloe vera components and their biological effects. Semin Integr Med 1(1):53–62
Choi SW, Son BW, Son YI, Park YI, Lee SK, Chung MH (2001) The wound-healing effect of a glycoprotein fraction isolated from aloe vera. Br J Dermatol 145(4):535–554
Chopra RN, Nayar SL, Chopra IC (1956) Glossary of Indian medicinal plants. CSIR, New Delhi
Cock IE (2011a) Problems of reproducibility and efficacy of bioassays using crude extracts, with reference to Aloe vera. Pharmacogn Commun 1(1):52–62
Cock IE (2011) Medicinal and aromatic plants—Australia, In: Ethnopharmacology section, Biological, Physiological and Health Sciences, Encyclopedia of Life Support Systems (EOLSS); Developed under the Auspices of the UNESCO, EOLSS Publishers, Oxford,UK. (http://www.eolss.net)
Cock IE (2014) The early stages of rheumatoid arthritis: new targets for the development of combinational therapies. OA Arthritis 2(1):5
Cock IE, Mohanty S (2011) Evaluation of the antibacterial activity and toxicity of Terminalia ferdinandia fruit extracts. Pharmacogn J 3(20):72–79
Cock IE, van Vuuren SF (2014) Anti-Proteus activity of some South African medicinal plants: their potential for the prevention of rheumatoid arthritis. Inflammopharmacology 22:23–36. doi:10.1007/s10787-013-0179-3
Cock IE, van Vuuren SF (2015a) A comparison of the antimicrobial activity and toxicity of six Combretum and two Terminalia species from Southern Africa. Pharmacogn Mag 11(41):208–218. doi:10.4103/0973-1296.149740
Cock IE, van Vuuren SF (2015b) South African food and medicinal plant extracts as potential antimicrobial food agents. J Food Sci Technol. doi:10.1007/s13197-015-1806-3
Cock IE, van Vuuren SF (2015c) The potential of selected South African plants with anti-Klebsiella activity for the treatment and prevention of ankylosing spondylitis. Inflammopharmacology 23:21–35. doi:10.1007/s10787-014-0222-z
Corner EJH (1997) Wayside Trees of Malaya, 4th edn. Malayan Nature Society 1: 217
Courtney R, Sirdaarta J, Matthews B, Cock IE (2015) Tannin components and inhibitory activity of Kakadu plum leaf extracts against microbial triggers of autoimmune inflammatory diseases. Pharmacogn J 7(1):18–31. doi:10.5530/pj.2015.7.2
Crouch R, Kimsey G, Priest DG, Sarda A, Buse MG (1978) Effect of streptozotocin on erythrocyte and retinal superoxide dismutase. Diabetologia 15:53–57
Cunningham AB, Garnett S, Gorman J, Courtenay K, Boehme D (2009) Eco-enterprises and Terminalia ferdinandiana: “Best Laid Plans” and Australian Policy Lessons. Econ Bot 63:16–28
Das B (1991) Materia medica of ayurveda. Jain Publishers, New Delhi, p 8
Das ND, Jung KH, Park JH, Choi MR, Lee HT, Kim MS, Lee SR, Chai YG (2012) Proteomic analysis of Terminalia chebula extract-dependent changes in human lymphoblastic T cell protein expression. J Med Food 15(7):651–657
Davi G, Ciabattoni G, Consoli A, Mezzetti A, Falco A, Santarone S, Pennese E, Vitacolonna E, Bucciarelli T, Constantini F, Capani F, Patrono C (1999) In vivo formation of 8-iso-prostaglandin F2a and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 99:224–229
Davis RH, Kabbani JM, Maro NP (1987) Aloe vera and wound healing. J Am Podiatr Med Assoc 77:165–169
Davis W, Ze’ev Ronai JR, Tew KD (2001) Cellular thiols and reactive oxygen species in drug-induced apoptosis. J Pharmacol Exp Ther 296(1):1–5
Dhetchuvi M, Lejoly J (1990) Contribution a’ la connaissance ds plantes me’dicinales du Nord- Est du Zaire. Mitt Inst Allg Bot Hamburg 23b:991–1006
Dongmo AB, Beppe, JG, Nole T, Kamanyi A (2006) Analgesic activities of the stem bark extract of Terminalia superba Engl. Et Diels (Combreaaceae). Pharmacologyonline 2:171–177
Dwivedi S (2007) Terminalia arjuna Wright & Arn.—a useful drug for cardiovascular disorders. J Ethnopharmacol 114:114–129
Dwivedi S, Udupa N (1989) Terminalia arjuna: pharmacognosy, phytochemistry, pharmacology and clinical use. A review. Fitoterpia 60:413–420
Dwivedi S, Chansouria JPN, Somani PN, Udupa KN (1987) Influence of certain indigenous drugs on the PGE like activity in the ischaemic rabbit aorta. Indian Drugs 2:378–382
Eesha BR, Mohanbabu AV, Meena KK, Sarath B, Vijay M, Lalit M, Rajput R (2011) Hepatoprotective activity of Terminalia paniculata against paracetamol induced hepatocellular damage in Wistar albino rats. Asian Pac J Trop Med 4:446–469
Emanuel R, Farber JC (1988) Repair, regeneration and fibrosis. In: Pathology. JB Lippincott Company, Philadelphia pp 77–89
Freemerman AJ, Powis G (2000) A redox-inactive thioredoxin reduces growth and enhances apoiptosis in WEHI7.2 cells. Biochem Biophys Res Commun 274:136–141
Fuhrman B, Aviram M (2001) Antiatherogenecity of nutritional compounds. Investig Drug J 4:82–92
Fyhrquist P, Mwasumbi L, Haeggstrom CA, Vuorela H, Hiltunen R, Vuorela P (2002) Ethnobotanical and antimicrobial investigation on some species of Terminalia and Combretum (Combretaceae) growing in Tanzania. J Ethnopharmacol 79:169–177
Gauthaman K, Maulik M, Kumari R, Manchanda SC, Dinda AK, Maulik SK (2001) Effect of chronic treatment with bark of Terminalia arjuna: a study on the isolated ischemic-reperfused rat heart. J Ethnopharmacol 75:197–201
Gill LS, Akinwunmi C (1986) Nigerian medicine practice and beliefs of the Ondo people. J Ethnopharmacol 18:257–266
Gomes A, Neuwirth O, Freitas M, Couto D, Ribeiro D, Figueiredo AGPR, Silva AMS, Seixas RSGR, Pinto DCGA, Tomé AC, Cavaleiro JAS, Fernandes E, Lima JLFC (2009) Synthesis and antioxidant properties of new chromone derivatives. Bioorganic Med Chem 17(20):7218–7226
Grover IS, Bala S (1992) Antimutagenic activity of T. chebula (myroblan) in Salmonella typhimurium. Indian J Exp Biol 30(4):339–341
Halliwell B (1996) Vitamin C: antioxidant or pro-oxidant in vivo? Free Radical Res 25:439–454
Hamilos DL, Zelarney P, Mascali JJ (1989) Lymphocyte proliferation in glutathione-depleted lymphocytes: direct relationship between glutathione availability and the proliferative response. Immunopharmacology 18:223–235
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57–70
Hazra B, Sarkar R, Biswas S, Mandal N (2010) Comparative study of the antioxidant and reactive oxygen species scavenging properties in the extracts of the fruits of Terminalia chebula, Terminalia belerica and Emblica officinalis. BMC Complement Altern Med 10:20
Herbert V, Shaw S, Jayatileke E (1996) Vitamin C driven free radicals generation from iron. J Nutr 126:1213–1220
Hertog MG, Bueno-de-Mesquita HB, Fehily AM, Sweetnam PM, Elwood PC, Kromhout D (1996) Fruit and vegetable consumption and cancer mortality in the caerphilly study. Cancer Epidemiol Biomark Prev 5:673–677
Ishihara M, Sakagami H (2003) Application of semiempirical method to estimate the cytotoxic activity of gallic acid and its related compounds. Anticancer Res 23:2549–2552
Jain S, Yadav PP, Gill V, Vasudeva N, Singla N (2009) Terminalia arjuna a sacred medicinal plant; phytochemical and pharmacological profile. Phytochem Rev 8(2):491–502
Jaiwal BV, Shaikh FK, Waghire HB, Sarwade BP (2012) Comparative anti-oxidative potential of barks phenolics of genus Terminalia. Int J Sci Pharma Educ Res 1(4):6–10
Joel LS (1995) The dual roles of nutrients as antioxidants and pro-oxidants: Their effects of tumor cell growth. In: Proceeding of the “Prooxidant Effects of Antioxidant Vitamins” experimental biology meeting, Atlanta, GA, Edited by Herbert V, American Society of Nutrition; Bethesda, MD pp 1221–1226
Johnson PD (2003) Acerola (Malpighia glabra L., M. punicifolia L., M. emarginata D.C.): agriculture, production and nutrition. World Rev Nutr Diet 91:67–75
Jueschke H, Knight TR (2003) The role of oxidant stress and species in acetaminophen hepatotoxicity. Toxicol Lett 144:279–288
Kamboj VP (2000) Herbal medicine. Curr Sci 78:35–39
Kankri E, Vaali K, Knowles RG, Lahde M, Korppela R, Vapaatalo H, Moilanen E (2001) Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl] acetamidine. J Pharmacol Exp Ther 298:1128–1132
Kannan M, Dasari A, Karthikeyan M, Ashokkumar J, Rajasekar S (2012) Effect of Terminalia bellerica fruit Roxb on Alloxan induced diabetic related atherosclerosis on Wistar albino rats. Int J Phytopharmacol 3(1):5–9
Karalliedde L, Gawarammana I (2008) Traditional Herbal Medicines. A Guide To Their Safe Use In: Shaw D (ed) Hammersmith Press Ltd London
Kasabri V, Flatt PR, Abdel-Wahab YHA (2010) Terminalia bellerica stimulates the secretion and action of insulin and inhibits starch digestion and protein glycation in vitro. Br J Nutr 103:212–217
Kaur S, Michael H, Arora S, Härkönen PL, Kumar S (2005) The in vitro cytotoxic and apoptotic activity of Triphala: an Indian herbal drug. J Ethnopharmacol 97:15–20
Khanna AK, Chander C, Kapoor NK (1996) Terminalia arjuna: an Ayurvedic cardiotonic regulates lipid metabolism in hyperlipidemic rats. Phytother Res 10:663–665
Kim HS, Lee JH, Kim IK (1996) Intracellular glutathione level modulates the induction of apoptosis by delta 12-prostaglandin J2. Prostaglandins 51:413–425
Klein R (1995) Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18:258–268
Konczak I, Zabaras D, Dunstan M, Aguas (2010) Antioxidant capacity and hydrophilic phytochemicals in commercially grown Australian fruits. Food Chem 123:1048–1054
Kumar GPS, Arulselvan P, Kumar DS, Subramanian SP (2006) Anti-diabetic activity of fruits of Terminalia chebula streptozotocin induced diabetic rats. J Health Sci 52(3):283–291
Kuo PL, Hsu YL, Lin TC, Chang JK, Lin CC (2005) Induction of cell cycle arrest and apoptosis in human non-small cell lung cancer A549 cells by casuarinin from the bark of Terminalia arjuna Linn. Anticancer Drugs 16(4):409–415
Lassak EV, McCarthy T (2006) Australian medicinal plants. New Holland Publishers, Australia
Lastra CA, Villegas I (2007) Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans 35:1156–1160
Lee KY, Park JH, Chung MH, Park YI, Kim KW, Lee YJ, Lee SK (1997) Aloesin up-regulates cyclin E/CDK2 kinase activity via inducing the protein levels of cyclin E, CDK2, and CDC25A in SK-HEP-1 cells. IUBMB Life 41(2):285–292
Li K, Diao Y, Zhang H, Wang S, Zhang Z, Yu B, Huang S, Yang H (2011) Tannin extracts from immature fruits of Terminalia chebula Fructus Retz. Promote cutaneous wound healing in rats. BMN Compliment Altern Med 11:86
Lin TC, Chien SC, Chen HF, Hsu FL (2001) Tannins and related compounds from Combretaceae plants. Chin Pharm J 52:1–26
Lin SZ, Tong HF, Chen KG, Jing H, Yang X, Zheng SS (2010) Effect of emodin in suppressing acute rejection following liver allograft transplantation in rats. Chin J Integr Med 16(2):151–156
Lin LT, Chen TY, Chung CY, Noyce RS, Grindley TB, McCormick C, Lin TC, Wang GH, Lin CC, Richardson CD (2011) Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spread. J Virol 85(9):4386–4398
Losso JN, Bansode RR, Trappey A, Bawadi HA, Truax R (2004) In vitro anti-proliferative activities of ellagic acid. J Nutr Biochem 15:672–678
Macpherson G (1992) Inflammation. Blacks Medical Dictionary; A and C Black, London, UK
Makino Y, Yoshikawa N, Okamoto K, Hirota K, Yodoi J, Makino I, Tanaka H (1999) Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function. J Biol Chem 274:3182–3188
Manna P, Sinha M, Sil PC (2006) Aqueous extract of Terminalia arjuna prevents carbon tetrachloride induced hepatic and renal disorders. BMC Complenent Altern Med 6:33
Maregesi S, Van Miert S, Pannecouque C, Feiz Haddad MH, Hermans N, Wright CW, Vlietinck AJ, Apers S, Pieters L (2010) Screening of Tanzanian medicinal plants against Plasmodium falciparum and human immunodeficiency virus. Planta Med 76:195–201
Martikainen JA, Ottelin AM, Kiviniemi V, Gylling H (2007) Plant stanol esters are potentially cost-effective in the prevention of coronary heart disease in men: bayesian modelling approach. Eur J Cardiovasc Prev Rehabil 14:265–272
Martino VS, Lόpez P, Martinez Irujo JJ, Sanromán M, Cuevas MT, Santiago E, Lasarte JJ, Font M, Coussio JD, Mongue A (2002) Inhibitory effect against polymerase and ribonuclease activities of HIV-reverse transcriptase of the aqueous leaf extract of Terminalia triflora. Phytother Res 16:778–780
Masoka P, Eloff JN (2005) The diversity of antifungal compounds of six South African Terminalia species (Combretaceae) determined by bioautography. Afr J Biotechnol 4(12):1425–1431
Masoka P, Eloff JN (2007) Screening of twenty-four South African Combretum and six Terminalia species (Combretaceae) for antioxidant activities. Afr J Tradit Complement Alter Med 4(2):231–239
Mbwambo ZH, Erasto P, Nondo RO, Innocent E, Kidukuli AW (2011) Antibacterial and cytotoxic activities of Terminalia stenostachya and Terminalia spinosa. Tanzania J Health Res 13(2):1–8
McGaw LJ, Rabe T, Sparg SG, Jäger AK, Ejoff JN, van Staden J (2001) An investigation on the biological activity of Combretum species. J Ethnopharmacol 75:45–50
Mety SS, Mathad P (2011) Antioxidative and free radical scavenging activities of Terminalia species. Int J Biotechnol 2(5):119–127
Mgbemene CN, Ohiri FC (1999) Anti-sickling potential of Terminalia catappa leaf extract. Pharm Biol 37(2):152–154
Middleton E, Kandaswami C, Theorharides TC (2000) The effect of plant flavonoids on mammalial cells: inflammation, heart disease and cancer. Pharmacol Rev 52:673–751
Miller JB, James KW, Maggiore PM (1993) Tables of composition of Australian Aboriginal foods. Aboriginal Studies Press, p 256
Mochizuki M, Hasegawa N (2007) Anti-inflammatory effect of extract of Terminalia sericea roots in an experimental model of colitis. J Health Sci 53(3):329–331
Mohanty S, Cock IE (2012) The chemotherapeutic potential of Terminalia ferdinandiana: phytochemistry and bioactivity. Pharmacogn Rev 6(11):29–36
Momo CEN, Ngwa AF, Dongmo IF, Oben JE (2009) Antioxidant properties and α-amylase inhibition of Terminalia superba, Albizia sp., Cola nitida, Cola odorata and Harungana madagascarensis used in the management of diabetes in Cameroon. J Health Sci 55(5):732–738
Moon EJ, Lee YM, Lee OH, Lee MJ, Lee SK, Chung MH, Park YI, Sung CK, Choi JS, Kim KW (1999) A novel angiogenic factor derived from Aloe vera gel: b-sitosterol, a plant sterol. Angiogenesis 3:117–123
Moshi MJ, Mbwambo ZH (2005) Some pharmacological properties of extracts of Terminalia sericea roots. J Ethnopharmacol 97:43–47
Moskaug JO, Carlsen H, Myhrstad MC, Blomhoff R (2005) Polyphenols and glutathione synthesis regulation. Am J Clin Nutr 81:277–835
Mudi SY, Muhammad A (2009) Antimalaria activity of ethanolic extracts of leaves of Terminalia catappa L. Combretaceae (Indian almond). Bayero. J Pure Appl Sci 2(1):14–18
Nadkarni AK (1976) Terminalia chebula. In: Nadkarni Dr. KM Indian Materia Madica, 3rd edn, Bombay, Popular Prakashan Pvt. Ltd.; 1202-11
Nagappa AN, Thakurdesai PA, Rao NV, Singh J (2003) Antidiabetic activity of Terminalia catappa Linn. fruits. J Ethnopharmacol 88:45–50
Nair S, Nagar R (1997) Antioxidant flavonoids in common Indian foods. South Asian J Prev Cardiol 1:33–35
Nair S, Nair R, Gupta R (1996) Dietary antioxidant, phenolics and flavonoids in coronary heart disease (Abstract). Indian Heart J 48:545
Nammi S, Gudavalli R, Ravindra Babu BS, Lodagala DS, Boini KM (2003) Possible mechanisms of hypotension produced 70 % alcoholic extract of Terminalia arjuna (L.) in anaesthetized dogs. BMC Complement Altern Med 3:5
Netzel M, Netzel G, Tian Q, Schwartz S, Konczak I (2007) Native Australian fruits—a novel source of antioxidants for food. Innov Food Sci Emerg Technol 8:339–346
Newman DJ, Cragg GM (2007) Natural products as sources of new drugs over the last 25 years. J Nat Prod 70(3):461–477
Njomem GBSN, Kamgang R, Soua PRN, Oyono JLE, Njikam N (2009) Protective effect of methanol-methylene chloride extract of Terminalia glaucescens leaves on streptozotocin-induced diabetes in mice. Trop J Pharm Res 8(1):19–26
Nkoble NK (2009) Antidiabetic activity of pentacyclic triterpenes and flavonoids isolated from stem bark of Terminalia sericea Burch. Ex DC. Masters thesis; dept Plant Science: University of Pretoria
Ohno Y, Fukuda K, Takemura G, Toyota M, Watanabe M, Yasuda N et al (1999) Induction of apoptosis by gallic acid in lung cancer cells. Anticancer Drugs 10:845–851
Okamoto K, Tanaka H, Ogawa H, Makino Y, Eguchi H, Hayashi S, Yoshikawa N, Poellinger L, Umesono K, Makino I (1999) Redox-dependent regulation of nuclear import of the glucocorticoid receptor. J Biol Chem 274:10363–10371
Peluso MR (2006) Flavonoids attenuate cardiovascular disease, inhibit phosphodiesterase and modulate lipid homeostasis in adipose tissue and liver. Exp Biol Med (Maywood) 231:1287–1299
Penckofer S, Schwertz D, Florczak K (2002) Oxidative stress and cardiovascular disease in type 2 diabetes: the role of antioxidants and prooxidants. J Cardiovasc Nurs 16(2):68–85
Pettit GR, Hoard MS, Doubek DL, Schmidt JM, Pettit RK, Tackett LP, Chapuis JC (1996) Antineoplastic agents 338. The cancer cell growth inhibitory constituents of Terminalia arjuna (Combretaceae). J Ethnopharmacol 53:57–63
Pinmai K, Chunlaratthanabhorn S, Ngamkitidechakul C, Soonthornchareon N, Hahnvajanawong C (2008) Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents: doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells. World J Gastroenterol 14(10):1491–1497
Pinmai K, Hiriote W, Soonthornchareonnon N, Jongsakul K, Sireeratawong S, Tor-Udom S (2010) In vitro and in vivo antiplasmoidal activity and cytotoxicity of water extracts of Phyllanthus emblica, Terminalia chebula and Terminalia bellerica. J Med Assoc Thail 93(Suppl 7):S120–S126
Planes de Banchero E, Souto J (1969) Actividad antivirica de algunas plantas indigenas. Rev Invest Agropec (INTA Buenos Aires) 6:155–171
Potter JD (1997) Cancer prevention: epidemiology and experiment. Cancer Lett 114:7–9
Pyke DA (1977) Genetics of diabetes. J Clin Endocrinol Metab 6:285–303
Ragavan B, Kumari K (2006) Effect of Terminalia arjuna stem bark extract on antioxidant status in liver and kidney of Alloxan diabetic rats. Indian J Physiol Pharmacol 50(2):133–142
Rahimi R, Nikfar S, Larijani B, Abdollahi M (2005) A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 59:365–373
Rahman A, Shahabuddin M, Hadi SM, Parish J (1990) Complexes involving quercetin, DNA and Cu(II). Carcinogenesis 11:2001–2003
Rahman AU, Zareen S, Choudhary MI, Akhtar MN, Shujaat S, Ngounou FN (2005) Some chemical constituents of Terminalia glaucescens and their enzyme inhibition activity. Zeitschrift für Naturforschung B, Chem Sci 60(2):347–350
Ramachandran S, Rajasekaran A, Manisenthilkumar KT (2012) Investigation of hypoglycaemic, hydrolipidemic and antioxidant activities of aqueous extract of Terminalia paniculata bark in diabetic rats. Asian Pac J Trop Biomed 2:262–268
Rane MM, Mengi SA (2003) Comparative effect of oral administration and topical application of alcoholic extract of Terminalia arjuna on experimental wounds in rats. Fitoterapia 74:553–558
Rao NK, Nammi S (2006) Antidiabetic and renoprotective effects of the chloroform extract of Terminalia chebula Retz. Seeds in streptozotocin-induced diabetic rats. BMC Complement Altern Med 6:17
Rao BK, Sudarshan PR, Rajasekhar MD, Nagaraju N, Rao CA (2003) Antidiabetic activity of Terminalia pallida fruit in Alloxan induced diabetic rats. J Ethnopharmacol 85:169–172
Rayan P, Matthews B, McDonnell PA, Cock IE (2015) Terminalia ferdinandiana extracts as inhibitors of Giardia duodenalis proliferation: a new treatment for giardiasis. Parasitol Res 114:2611–2620. doi:10.1007/s00436-015-4465-4
Reddy DB, Reddanna P (2009) Chebulagic acid (CA) attenuates LPS-induced inflammation by suppressing NK-кB and MAPK avtivation in RAW 264.7 macrophages. Biochem Biophys Res Commun 381:112–117
Reddy DB, Reddy TC, Jyotsna G et al (2009) Chebulagic acid, a COX-LOX dual inhibitor isolated from the fruits of Terminalia chebula Retz., induces apoptosis in COLO-205 cell line. J Ethnopharmacol 124:506–512
Rice-Evans C, Miller N (1997) Paganga. Antioxidant properties of phenolic compound. Trends Plant Sci 2:152–159
Rivas M, Distefano A (1973) Estudio de la acciόn antiviral de Terminalia triflora. Rev Asoc Argent Microbiol 5:55–56
Rivas M, Distefano A Graziano MN (1971) Congreso Latinoamerico de Microbiologia. Punta del Este (Abstract 21)
Robbins MJ, Sharp RA, Slonium AE, Burr IM (1980) Protection against streptozotocin-induced diabetes by superoxide dismutase. Diabetologia 18:55–58
Robertson RP, Chen M (1977) A role for prostaglandin E in defective insulin secretion and carbohydrate intolerance in diabetes mellitus. J Clin Invest 60:747–753
Rode T, Frauen M, Muller BW, Dusing HJ, Schonrock U, Mundt C, Wenck H (2003) Complex formation of sericoside with hydrophilic cyclodextrins: improvement of solubility and skin penetration in topical emulsion based formulations. Eur J Pharm Biopharm 55:191–198
Ruefli AA, Davis JE, Sutton VR, Trapani JA, Smyth MJ, Johnstone RW (2001) Disecting the apoptopic mechanisms of chemotherapeutic drugs and lymphocytes to design effective anticancer therapies. Drug Dev Res 52:549–557
Ruff JC (2003) Wine and polyphenols related to platelet aggregation and atherothrombosis. Drugs Exp Clin Res 25:125–131
Sabu MC, Kuttan R (2009) Antidiabetic and antioxidant activity of Terminalia belerica Roxb. Indian J Exp Biol 47(4):270–275
Saguna L, Singh S, Sivakumar P, Sampath P, Chandrakasan G (2002) Influence of Terminalia chebula on dermal wound healing in rats. Phytother Res 16:227–231
Sakaguchi N, Inoue M, Isuzugawa K, Ogihara Y, Hosaka K (1999) Cell death-inducing activity by gallic acid derivatives. Biol Pharm Bull 22:471–475
Samuni A, Aronovitch J, Godinger D, Chevion M, Czapsk G (1983) On the cytotoxicity of vitamin C and metal ions. A site-specific Fenton mechanism. Eur J Biochem 137:119–124
Sandhya T, Mishra KP (2006) Cytotoxic response of breast cancer cell lines, MCF-7 and T 47 D to triphala and its modification by antioxidants. Cancer Lett 238:304–313
Sandhya T, Lathika KM, Pandey BN, Mishra KP (2006) Potential of traditional Ayurvedic formulation, triphala, as a novel anticancer drug. Cancer Lett 231:206–214
Sandler S, Andersson A (1982) The partial protective effect of the hydroxyl radical scavenger dimethyl urea on streptozotocin-induced diabetes in the mouse in vivo and in vitro. Diabetologia 23:374–378
Sasidharan I, Sundaresan A, Nisha VM, Kirishna MS, Raghu KG, Jayamurthy P (2012) Inhibitory effect of Terminalia chebula Retz. Fruit extracts on digestive enzyme related to diabetes and oxidative stress. J Enzyme Inhib Med Chem; Early online: 1–9
Shaba P, Pandey NN, Sharma OP, Rao RJ, Singh RK (2009a) In vitro trypanocidal activity of comparative extraction of Terminalia bellirica (Combretaceae) dried fruits with solvents of different polarities against Trypanosma evansi. Int J Vet Med 6(1)
Shaba P, Pandey NN, Sharma OP, Rao RJ, Singh RK (2009b) Therapeutic evaluation of Terminalia bellirica (Combretaceae) dried fruits against Trypanosma evansi. Int J Vet Med 7(1)
Shaila HP, Udupa SL, Udupa AL (1998) Hypolipidemic activity of three indigenous drugs in experimentally induced atherosclerosis. Int J Cardiol 67:119–124
Sharma PN, Shoeb PN, Kapil RS, Popli SP (1982) Arjunolone—a new flavone from stem bark of Terminalia arjuna. Indian J Chemi 21B:263–264
Shi Y, Sahu RP, Srivastava SK (2008) Triphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis. BMC Cancer 8:294
Shih CC, Wu YW, Lin WC (2002) Antihyperglycemic and antioxidant properties of Anoectochilus Formosanus in diabetic rats. Clin Exp Pharmacol Physiol 29:684–688
Shinde SL, Junne SB, Wadje SS, Baig MMV (2009) The diversity of antibacterial compounds of Terminalia species (Combretaceae). Pak J Biol Sci 12(22):1483–1486
Simons SS, Pratt WB (1995) Glucocorticoid receptor thiols and steroid-binding activity. Methods Enzymol 251:406–422
Singh S, Farhan AS, Ahmad A, Khan NU, Hadi SM (2001a) Oxidative DNA damage by capsaicin and dihydrocapsaicin in the presence of Cu(II). Cancer Lett 169:139–146
Singh R, Barden A, Mori T, Beilin L (2001b) Advanced glycation end-products: a review. Diabetologia 44:129–146
Sirdaarta J, Matthews B, Cock IE (2015a) Kakadu plum fruit extracts inhibit growth of the bacterial triggers of rheumatoid arthritis: identification of stilbene and tannin components. J Funct Foods 17:610–620. doi:10.1016/j.jff.2015.06.019
Sirdaarta J, Matthews B, White A, Cock IE (2015b) GC-MS and LC-MS analysis of Kakadu plum fruit extracts displaying inhibitory activity against microbial triggers of multiple sclerosis. Pharmacogn Commun 5(2):100–115. doi:10.5530/pc.2015.2.2
Sivalokanathan S, Ilyaaraja M, Balasubramanian MP (2006) Antioxidant activity of Terminalia arjuna bark extract on N-nitrosodiethylamine induced hepatocellular carcinoma in rats. Mol Cell Biochem 281:87–93
Sumithira P, Dhivya Mangala S, Sophie AM, Padma Latha C (2012) Antiviral and antioxidant activities of two medicinal plants. Int J Curr Sci 256–261
Tager H (1984) Abnormal products of human insulin gene. Diabetes 33:693–699
Takahashi S, Tanaka H, Hano Y, Ito K, Nomura T, Shigenobu K (1997) Hypotensive effects in rats of hydrophyllic extract from Terminalia arjuna containing tannin-related compounds. Phytother Res 1:424–427
Tandon S, Rastogi R, Kapoor NK (1995) Protection by abana, a herbomineral preparation, against myocardial necrosis in rats induced by isoproterenol. Phytother Res 9:263–266
Tome ME, Baker AF, Powis G, Payne CM, Briehl MM (2001) Catalase-overexpressing thymocytes are resistant to glucocorticoid-induced apoptosis and exhibit increased net tumor growth. Cancer Res 61:2766–2773
Tripathi VK, Singh B (1996) Terminalia arjuna- its present status (a review). Orient J Chem 12(1):1–16
Tsuda T, Horio F, Uchida K, Aoki H, Osawa T (2003) Dietary cyaniding 3-O-b- D-glucoside-rich purple corn colour prevents obesity and ameliorates hyperglycemia in mice. J Nutr 133:2125–2130
Udupa KN (1986) Scope of use of Terminalia arjuna in ischaemic heart disease. Ann Natl Acad Indian Med 1:54
Vessby J, Basu S, Mohsen R, Berne C, Vessby B (2002) Oxidative stress and antioxidant status in type 1 diabetes mellitus. J Intern Med 251:69–76
Vita JA (2005) Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am J Clin Nutr 81:292S–297S
Vivancos M, Moreno JJ (2005) β-Sitosterol modulates antioxidant enzyme response in RAW 264.7 macrophages. Free Radic Biol Med 39(1):91–97
Walsh G (2003) Biopharmaceuticals: Biochemistry and Biotechnology, 3rd edn. Wiley, Chinchester
Wilma DSC, Kavya N, Kulkarni S (2011) Evaluation of insulin sensitivity status in polycystic ovarian syndrome. Asian Pac J Trop Disease 1(1):67–70
Woods B (1995) A study of the intra-specific variations and commercial potenatial of Terminalia fredinandiana (the kakadu Plum). M.Sc. thesis, Northern Territory University, Australia
Wu CC, Lu YH, Wei BL, Yang SC, Won SJ, Lin CN (2008) Phloroglucinols with prooxidant activity from Garcinia subelliptica. J Nat Prod 71:246–250
Yagi A, Kabash A, Okamura N, Haraguchi H, Moustafa SM, Khalifa TI (2002) 2002, Antioxidant, free radical scavenging and anti-inflammatory effects of aloesin derivatives in Aloe vera. Planta Med 68(11):957–960
Yoon JW, Austin M, Onodera T, Notkins AC (1979) Virus induced diabetes mellitus: isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 300:1173–1179
Youdim KA, Spencer JP, Schroeter H, Rice-Evans CA (2002) Dietary flavonoids as potential neuroprotectans. Biol Chem 383:503–519
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cock, I.E. The medicinal properties and phytochemistry of plants of the genus Terminalia (Combretaceae). Inflammopharmacol 23, 203–229 (2015). https://doi.org/10.1007/s10787-015-0246-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-015-0246-z